CLINICAL TRIALS PROFILE FOR URECHOLINE
✉ Email this page to a colleague
All Clinical Trials for URECHOLINE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01031043 ↗ | Topical Bethanechol for Improvement of Esophageal Dysmotility | Completed | Augusta University | Phase 1 | 2009-11-01 | The purpose of this research project is to determine the effect of a drug called bethanechol on swallowing function in patients with Ineffective Esophageal Motility (IEM). This drug is FDA approved for use in treating other conditions, but not for the treatment of IEM. There is currently no approved therapy for the treatment of IEM. This information is important for the possible development of new ways of treating patients with IEM and for the effectiveness of topically applied Bethanechol on patients with IEM. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for URECHOLINE
Condition Name
Clinical Trial Locations for URECHOLINE
Trials by Country
Clinical Trial Progress for URECHOLINE
Clinical Trial Phase
Clinical Trial Sponsors for URECHOLINE
Sponsor Name